🇺🇸 FDA
Patent

US 7229628

Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling

granted A61KA61K2039/505A61K2039/55522

Quick answer

US patent 7229628 (Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling) held by The Regents of the University of California expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K2039/55522, A61K35/13, A61K38/00